Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel plus Gemcitabine in Advanced Pancreatic Cancer

Zev A. Wainberg, Howard S. Hochster, Edward J. Kim, Ben George, Aparna Kaylan, E. Gabriela Chiorean, David M. Waterhouse, Martin Guiterrez, Aparna Parikh, Rishi Jain, Daniel Ricardo Carrizosa, Hatem H. Soliman, Thomas Lila, David J. Reiss, Daniel W. Pierce, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin OngPeter J. O’Dwyer

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel plus Gemcitabine in Advanced Pancreatic Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences